Background: This cross-sectional study assesses cytokine levels in peri-implant crevicular fluid (PICF)/gingival crevicular fluid (GCF) and a selection of subgingival/submucosal plaque bacteria from clinically healthy or diseased sites in the same individuals.
I
nflammatory reactions around dental implants may affect only the periimplant mucosa, leading to mucositis, or also the peri-implant hard tissues, leading to peri-implantitis. 1, 2 Peri-implant mucositis is characterized by bleeding on probing (BOP) without bone loss, whereas peri-implantitis is defined as loss of supporting bone around osseointegrated implants that is often associated with pocket formation, suppuration, and mobility of the implant. 3 Prevalence of peri-implant mucositis varies between 36.3% and 64.6% and peri-implantitis between 8.9% and 47.1%. 4 Peri-implant diseases may disturb esthetics, as well as function of implants, and progressive bone loss may cause implant failure. 5 Therefore, early detection and treatment of peri-implant diseases is of utmost importance. Various clinical measures, including probing depth (PD), BOP, and plaque index (PI) are used to assess peri-implant health. 6 Inflammatory process of peri-implant tissues has been examined in periimplant crevicular fluid (PICF) samples. 7 PICF is a valuable biofluid that is easily obtained by non-invasive methods for examining biochemical mediators with potential for early detection of periimplant inflammatory diseases. Recent studies have demonstrated that various biomarkers in PICF are selectively upregulated at sites of inflammation and tissue breakdown compared with healthy sites. 8, 9 Major differences between gingivitis and periodontitis sites are presence of a dysbiotic microbiota and a susceptible host. 10, 11 Dysbiosis can either be the cause or consequence of disease. Homeostasis is a condition of equilibrium or stability in a known system. 12 Recently, it has been proposed that periodontitis fundamentally represents disruption of hostmicrobial homeostasis by dysbiosis of the periodontal microbiota. 10 Periodontal pathogens and their virulence factors stimulate the release of immunologic biomarkers such as tumor necrosis factor-a (TNF-a), interleukin (IL)-1b, IL-6, IL-17, and receptor activator of nuclear factor-kB ligand (RANKL). 13 Socransky et al. 14 stated that mainly anaerobic Gram-negative bacterial species such as Tannerella forsythia (Tf), Treponema denticola (Td), and Porphyromonas gingivalis (Pg) are associated with periodontal destruction. To date, levels of key biologic mediators in gingival crevicular fluid (GCF) and PICF samples have been comparatively investigated in few studies. 15, 16 It was hypothesized that possible differences in cytokine content and/or bacterial species between healthy and diseased sites may reveal similar factors acting in the pathogenesis of periodontitis and peri-implantitis. Therefore, the aim of the present study was to comparatively assess levels of IL-1b, IL-17A, IL-17F, IL-17E, soluble (s)RANKL, and osteoprotegerin (OPG) in PICF/GCF samples, and presence of Aggregatibacter actinomycetemcomitans (Aa), Actinomyces naeslundi (An), Fusobacterium nucleatum (Fn), Pg, Prevotella intermedia (Pi), Streptococcus mutans (Sm), Td, Tf, and Veillonella dispar (Vd) in subgingival/submucosal plaque samples from healthy and diseased teeth and implants in the same individuals.
MATERIALS AND METHODS

Study Population
Fifteen systemically healthy patients (eight males and seven females, aged 48 to 60 years; mean age: 54.3 years) were recruited in this cross-sectional study at the Department of Periodontology, School of Dentistry, Ege University, _ Izmir, Turkey, from January 2014 to September 2014. Participants were sequentially recruited from patients referred for periodontal/ peri-implant disease treatment. Healthy and diseased sampling sites were matched both for implants and natural teeth in the same individuals. Inclusion criteria were as follows: 1) being systemically healthy and 2) having an implant-supported prosthesis in function for ‡12 months with at least one implant diagnosed with peri-implantitis based on presence of at least one site with PD >4 mm with BOP and/or suppuration and radiographic evidence of bone loss ‡2 mm. 4 Moreover, participants were required to have a clinical diagnosis of periodontitis based on the following: 1) presence of PD >4 mm; 2) clinical attachment level (CAL) ‡3 mm; and 3) BOP. Peri-implant mucositis was diagnosed on the presence of BOP without loss of supporting bone. 3, 4 Diagnosis of gingivitis was assigned when there was BOP, PD <4 mm, and no clinical sign of periodontitis. 17 Uninflamed implant and tooth sites with PD <3 mm and CAL <3 mm were considered to be healthy.
Exclusion criteria were as follows: 1) presence of any known systemic disease; 2) history of aggressive periodontitis; 3) antibiotic and/or anti-inflammatory drug usage within the last 6 months before the start of the study; and 4) presence of <16 teeth. This study was approved by the Institutional Review Board, School of Medicine, Ege University, _ Izmir, Turkey (protocol no. 13-11.1/9). The study protocol was explained, and written informed consent was received from each participant before study enrollment.
Sampling sites were selected according to the health status of the peri-implant/periodontal tissues in the same individuals. Teeth with the most severe periodontal tissue destruction compared with periimplantitis sites as well as the most severely inflamed sites were included in the periodontitis/gingivitis groups. The two types of investigated dental implants ‡ § were of conical connection design.
Clinical Periodontal Measurements PD, CAL, BOP, PI scores, and keratinized tissue width (KrTW) were recorded. The clinical periodontal and peri-implant examinations were performed by two trained periodontists (Ö G, PG), calibrated initially and also at 6 months of the study. Initial intraexaminer k values were 0.96 (PD) and 0.86 (CAL) for PG and 0.93 (PD) and 0.79 (CAL) for Ö G. The interexaminer values were 0.92 (PD) and 0.75 (CAL). BOP was deemed positive if it occurred within 15 seconds after probing. Presence of visible plaque was recorded dichotomously by visual examination. 18 A periodontal probe i was used for measurement of PD and CAL at four sites (mesio-buccal, mid-buccal, disto-buccal, mid-lingual) of each tooth/implant present, except third molars. Bitewing radiographs were taken from all participants to determine presence of bone loss around the dental implants.
Biofluid and Plaque Sampling
All samples were obtained before clinical periodontal recordings. GCF/PICF samples were obtained by the standard filter paper strips ¶ from the buccal aspects of teeth/implants. Filter paper strips were placed in the gingival/peri-implant sulcus and left in place for 30 seconds. Care was taken to avoid mechanical trauma, and strips visually contaminated with blood were discarded. Sample volumes were estimated with a calibrated instrument. # Before subgingival/submucosal plaque sampling, supragingival/supramucosal plaque was removed carefully by sterile curets.** The site was isolated using cotton rolls and gently dried with an air syringe to avoid contamination with saliva. Another sterile Gracey curet was inserted to the bottom of the sulcus/pocket and removed, applying a slight force toward the root surface. The tip of the curet was inserted in the microcentrifuge tube containing 0.5 mL distilled water and shaken until the plaque was removed from the curet. All samples were immediately frozen and stored at -40°C until laboratory analyses.
Oral prophylaxis or non-surgical periodontal treatment was not initiated before sample collection, and individuals were enrolled in a periodontal treatment program as required.
Measurement of sRANKL, OPG, IL-1b, IL-17A, IL-17F, IL-17E, and Albumin in GCF/PICF Samples Commercial enzyme-linked immunosorbent assay (ELISA) kits were purchased for the measurement of OPG, † † sRANKL, ‡ ‡ IL-17A, § § IL-17E, ii IL-17F, ¶ ¶ and IL-1b, ## and assays were carried out according to recommendations provided by manufacturers. Optical densities were read at 450 nm with a background subtraction at 570 nm, and samples were compared with the standards. Minimum detection limits for the assays were as follows: OPG, 7.56 pg/ mL; sRANKL, 7.56 pg/mL; IL-1b, 0.39 pg/mL; IL-17A and IL-17F, 0.79 pg/mL; IL-17E and IL-17A/F, 1.59 pg/mL. Albumin levels were determined by ELISA as previously described. 19 Biochemical data were expressed as total amounts per sampling time (pg/30 seconds) and also as concentrations (pg/mL).
Preparation and Assessment of Genomic DNA
A Gram-positive DNA isolation kit*** was used to prepare genomic DNA from the pelleted microbes present in the GCF sample bacteria and from known quantities of laboratory strains of target microorganisms. 20 Amount and purity of DNA were checked at 260 and 280 nm (260/280 nm ratio = 1.8 to 2.0 = good DNA purity) using a spectrophotometer. † † † The DNA in standards and plaque samples was measured by fluorimetric analysis. ‡ ‡ ‡ DNA content of the target species was used to fix the copy number of its bacterial genome to use as a standard for each realtime quantitative polymerase chain reaction (RTqPCR) assay.
RT-qPCR
Real-time PCR § § § was used for detection and quantification of bacterial cell copy numbers in 1 mg plaque DNA. Primers and probes selected for the following bacteria were as published in the sources shown: Pg, Aa, Pi, Tf, Fn, [21] [22] [23] [24] Td, 25 An, Streptococcus oralis (So), and, Vd 26 were purchased. iiii On a thermal cycler, ¶ ¶ ¶ the PCR cycling parameters used were 10 minutes at 95°C and 40 cycles of 30 seconds at 95°C and 1 minute at 60°C. All primer sets were validated by running four serial 1/10 dilutions of the standard DNA and calculating the efficiency of the reaction (E) where E = 10 (-1/slope) -1 . All reaction efficiencies calculated were acceptable (between 91% and 104%). All primer sets failed to amplify DNA purified from different microbial standards.
Statistical Analyses
Previous studies on sRANKL and OPG in GCF 27 indicated that effect sizes (d/s) >2 were acceptable and that n >6 would be sufficient to achieve 90% statistical power in a parametric test. With regard to IL-17 cytokines in GCF, 28 n = 15 may be sufficient to give 90% statistical power with an effect size >1.25. Although the intention was to make direct comparisons in the same individuals, there were repeat observations from some patients and missing observations from others (Table 1 ). All samples were assayed separately, but in those individuals where more than one implant fell into the same category, these values were averaged. First, a Q-Q plot analysis indicated that the data were not normally distributed; therefore, distribution-free statistical tests were used. Second, for analysis of mixed dependent and independent data sets the approach described by Dubnicka et al. 29 was used. In brief, where there was direct concordance in sample numbers among disease categories, the Wilcoxon test was used for dependent sample comparisons in the same individuals. Where all samples were entirely independent among disease categories as between gingivitis and periodontitis, the Mann-Whitney U test was used to compare differences among the parameters recorded. Where there was a mixture of dependent and independent samples, a Monte Carlo method of 1,000 random data combinations was used in a permutation test (based on the Wilcoxon test). A Bonferroni correction was used to adjust the P value. Spearman correlations were performed to evaluate the relationship between clinical and biochemical data. All tests were performed at a significance level of a = 0.05. Statistical calculations were performed using two statistical software packages. ### **** RESULTS GCF/PICF and subgingival/submucosal plaque samples were obtained from a total of 97 implants/ teeth (58 implants, 39 natural teeth) in 15 patients. Clinical variables are presented in Table 1 . Clinical parameters were similar in the gingivitis and mucositis groups and in periodontitis and peri-implantitis groups (P >0.05). In the healthy implant group, PD, CAL, BOP, and PI data were significantly higher than the healthy tooth group (P <0.001; P = 0.01; P = 0.009, and P = 0.002, respectively).
Biomarkers
Biomarker data are outlined in Figures 1 and 2 . OPG total amounts and concentrations and albuminadjusted concentrations (data not shown) were significantly higher (P = 0.04, P = 0.01, and P = 0.03, respectively), and IL-1b, sRANKL levels, and sRANKL/OPG ratios were significantly lower in the healthy implant sites than in the mucositis and periimplantitis sites (all P = 0.001). sRANKL/OPG ratios were significantly lower at the healthy implant sites than at the mucositis and peri-implantitis sites (P = 0.04 and P = 0.008, respectively) (Fig. 1G) .
OPG concentrations were significantly higher at healthy teeth sites than gingivitis (P = 0.03) and periodontitis (P = 0.02) sites, and IL-1b levels, sRANKL levels, and sRANKL/OPG ratios were significantly lower (P = 0.002 and P = 0.02, respectively). IL-1b concentrations were higher at gingivitis sites than in the healthy group (P = 0.003). Comparisons of natural teeth and implants with similar clinical health state revealed significantly higher IL-1b levels in the healthy implant group than in natural teeth (P = 0.003) and significantly higher sRANKL concentrations at gingivitis than in mucositis sites (P = 0.004) (Fig. 1) .
Concentrations of IL-17A, IL-17F, and IL-17E were similar at healthy and diseased sites (Fig. 2) . There was no significant difference in concentrations of these cytokines in GCF with the exception of IL-17E concentration, which was significantly lower at gingivitis sites than at healthy tooth sites (P <0.05).
Comparisons of peri-implantitis and periodontitis samples revealed similar levels and concentrations of IL-17 family cytokines (Fig. 2) .
Microbiologic Parameters
Microbiologic data are presented in Figure 3 . Copy numbers of An, Pg, Fn, and Tf levels were significantly higher at the mucositis than healthy implant sites (P <0.05). Numbers of Fn, Pg, Pi, and Tf were significantly higher at peri-implantitis sites than at healthy implant sites (P <0.05). Fn, Pi, and Td levels were significantly higher at gingivitis sites than at healthy teeth (P <0.05). So, Td, Fn, and Tf levels were significantly greater at periodontitis sites than at healthy tooth sites (P <0.05). Periodontitis sites revealed significantly higher Pg, Prevotella oralis (Po), and So levels than gingivitis sites (P <0.05). An levels were significantly lower in healthy implants than in healthy teeth (P <0.05).
Pi and Td levels were lower at mucositis sites than at gingivitis sites (P <0.05). Po, So, and Td levels were significantly higher in periodontitis sites than in periimplantitis sites (P <0.05).
Correlations
At the implant sites, the amount of IL-1b and sRANKL/OPG ratio correlated positively with PD, (r = 0.497 and r = 0.293, respectively) and IL-1b concentration with PD (r = 0.228). There were significant negative correlations between OPG concentration and PD (r = -0.387) and among amounts of OPG at implant sites with PD (r = -0.277). There was also a significant positive correlation between the IL-17A/IL-17E ratio and CAL (r = 0.323) at implant sites. PICF volume correlated significantly with IL-1b (r = 0.659), sRANKL (r = 0.533), and the RANKL/OPG ratio (r = 0.332). At tooth sites, significant positive correlations were found between amount of IL-1b and PD (r = 0.511); amount of sRANKL, sRANKL/OPG, and PD (r = 0.375 and r = 0.397); and IL-1b concentrations and CAL (r = 0.223). Significant negative correlations consisted of OPG concentration with PD (r = -0.423) and OPG levels with PD (r = -0.348). GCF volume correlated with IL-1b (r = 0.742), sRANKL (r = 0.513), OPG (r = -0.372), and the RANKL/OPG ratio (r = 0.478). Box and whisker plots showing the amount (A) and concentration (B) of IL-1b; the amount (C) and concentration (D) of sRANKL; the amount (E) and concentration (F) of OPG; and the sRANKL:OPG ratio (G) in PICF from implant sites: clinically healthy, with mucositis, with peri-implantitis, and in GCF taken from teeth: clinically healthy, gingivitis, and periodontitis. *Statistically significant differences between implant sites and tooth sites with similar disease categories (P <0.05).
† Statistically significant differences among disease categories and the corresponding healthy implant or tooth sites (P <0.05).
‡ Statistically significant differences between gingivitis and periodontitis (P <0.05). Outliers are indicated by solid circles.
There were numerous significant correlations between microbiologic and clinical data ( Table 2 ). Significant positive correlations were found at both tooth and implant sites between PD and presence of Fn, Pg, Td, or Tf with the addition of Aa and Po at tooth sampling sites. In contrast, So showed a negative correlation with PD at tooth sites. At implant sites, Pi and An showed weak positive correlations with CAL, whereas Aa had a weak negative correlation with CAL (Table 2) .
Pg, Fn, Pi, Td, Tf, and Vd levels correlated positively with the amount of IL-1b. Pg, Pi, Td, and Tf correlated positively with the amount of sRANKL and the sRANKL/OPG ratio (Table 3 ). Significant negative correlations were found between Aa and the amount of sRANKL, sRANKL concentration, and sRANKL/ OPG ratio, and between Pg and OPG (Table 3) .
DISCUSSION
To the best knowledge of the authors, this is the first crosssectional study evaluating biomarkers and microbiologic data in implants versus natural teeth matched with regard to clinical health status in the same individuals. Implants and teeth from the same individuals have been studied before, but little information on their disease status was provided. 30 The present study investigates levels of IL-1b, IL-17, sRANKL, and OPG in GCF/PICF and presence and counts of Aa, An, Fn, Pg, Pi, Sm, Td, Tf, and Vd around teeth and implants with different health status in the same individuals.
A strength of this type of investigation is the ability to survey a large number of parameters for potential associations.
A major limitation of the present study, similar to other cross-sectional studies, 8, [30] [31] [32] is relating cause and effect of the disease and an accurate relationship among measurable parameters. Another limitation is the low number of sampling sites available for the periodontitis category to match with the peri-implantitis sites in the same individuals. The approach of matching different disease categories in same individuals severely limited the number of patients eligible for the study. This posed a significant challenge as an exact match of healthy sites with different disease categories was not possible; however, attempts to deal with this issue were made by carrying out permutation analysis. An alternative approach could be to combine diseased (IL-25) ; and (G) the IL-17A:IL-17E ratio in PICF from implant sites: clinically healthy, with mucositis, and with peri-implantitis and in GCF from tooth sites: clinically healthy, gingivitis, and periodontitis.
groups at implants and teeth to compare with corresponding healthy implants and teeth, respectively. This approach would still result in a degree of mismatch, making comparisons with inflamed implant and tooth sites difficult because of the different level of disease at these locations.
Implants with a conical implant-abutment connection had negligible bacterial contamination due to the decreased microgap and microleakage under in vitro conditions. Microgap and microleakage act as a reservoir of bacteria and may contribute to establishment of peri-implantitis. 33 For standardization purposes, only implants with a conical connection design were included in this study.
Proinflammatory cytokines induce alveolar bone resorption by increasing expression of RANKL and reducing OPG in osteoblasts and stromal cells. 34 Mogi et al. 27 reported significantly greater ratios of RANKL/ OPG in patients with periodontal disease. Vernal et al. 35 found higher levels of RANKL in untreated patients with chronic periodontitis (CP) than healthy controls. An increased RANKL/OPG ratio was reported in GCF samples obtained from periodontitis sites compared with gingivitis/healthy sites. 36 Rakic et al. 8 found higher sRANKL levels in peri-implantitis sites. However, Sarlati et al. 9 reported similar data in the study groups. In their study, 40 implants were categorized as clinically healthy, peri-implant mucositis, and peri-implantitis according to clinical and radiographic findings. Similar RANKL/OPG ratios were found in peri-implantitis sites and healthy controls. 8, 37 Duarte et al. 38 observed an increase in RANKL/OPG ratios in peri-implantitis. In the present study, the healthy implant group revealed significantly higher total OPG amounts and concentrations than the mucositis and peri-implantitis groups, together with significantly lower sRANKL levels and sRANKL/ OPG ratios. The present finding of a significantly higher OPG concentration in healthy teeth than gingivitis and periodontitis groups is consistent with the existing literature. 27, 35 sRANKL concentrations were significantly higher in the present gingivitis than the mucositis group. A recent study reported significantly higher IL-1b levels in peri-implantitis sites compared with healthy implants. 39 Accordingly, in the present study, significantly higher IL-1b levels were found in peri-implantitis sites than in healthy implants and also in gingivitis and periodontitis sites than in healthy teeth sites. These findings provide further support for the previous studies suggesting that peri-implant and periodontal diseases have similar patterns in terms of host response and bone destruction. However, when natural teeth and implants are compared, IL-1b levels were significantly higher in the healthy implant group than the healthy teeth sites. This, in part, contradicts findings of a longitudinal study that showed elevated IL-1a levels at healthy tooth sites compared with healthy implant sites 40 and is loosely in agreement with the cross-sectional study by Recker et al., 31 where IL-17A and TNF were higher at implant than at tooth sites. Furthermore, IL-1b and TNF levels were higher at implants than at teeth. 32 According to the present findings, sRANKL concentrations were significantly higher at the gingivitis than at mucositis sites. This may be explained by a rather more prominent innate immune response at peri-implant sites than natural teeth without bone resorption. However, in the current study, IL-1b, sRANKL, and OPG levels were similar in the peri-implantitis and periodontitis groups. Stacked bars represent, in alphabetical order, top to bottom: the cumulative copy numbers of microorganisms at implant and tooth sites (A) and the cumulative percentage of each organism at tooth and implant sites (B). Po = Prevotella oralis. Significant differences (P <0.05) among the sample sites for each organism are indicated. § Significantly higher at mucositis than healthy implant sites.
k Significantly higher at peri-implantitis sites than at healthy implant sites.
¶ Significantly higher at gingivitis sites than at healthy teeth.
# Significantly higher at the periodontitis sites than at healthy tooth sites. **Significantly higher at periodontitis sites than at gingivitis sites. † † Significantly lower in healthy implant samples than in healthy tooth samples.
‡ ‡ Significantly lower mucositis sites than at gingivitis sites. § § Significantly lower at peri-implantitis sites than at periodontitis sites.
The IL-17 family of cytokines consists of IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25), and IL-17F. IL-17A synergizes with other cytokines, including IL1b and TNF-a. 41 IL-17A increases RANKL expression and concomitantly decreases OPG expression in osteoblastic cells in vitro and in vivo. 42 IL-17F also plays a critical role in host defense on bacterial and fungal infection by recruiting neutrophils and producing antimicrobial peptides. 43 The presence of IL-17A/F heterodimers substantially influences the potency, specificity, and spectrum of the activity of cytokines. 44 In contrast with other IL-17 family cytokines, IL-17E is an anti-inflammatory cytokine, which opposes functions of IL-17A and IL-17F. 45 Evidence for this role of IL-17E in the oral environment is manifested in experiments with oral epithelial cells. In the current study, IL-17E concentrations were significantly lower at gingivitis sites than at healthy sites, but no significant differences were observed for the other IL-17 cytokines.
Lester et al. 42 found increased IL-17A concentrations in gingival tissue supernatants at sites of severe attachment loss where a positive correlation was detected between the tissue level of this cytokine and CAL. Increased IL-17 levels in patients with CP have been reported in other clinical studies. 28, 35 Indeed, local tissue expression of the IL-17 family probably contributes to higher amounts of IL-17 detected in the GCF of patients with periodontitis compared with healthy individuals. 28, 35 This finding may suggest an important role for IL-17 in the pathogenesis of CP. In the present study, GCF/PICF IL-17A, IL-17-F, and IL-17E levels and IL-17A/IL-17E ratios were similar at all evaluated sites. It has to be conceded that the relatively low numbers of samples in different study groups may have a role in this finding, because studies with larger GCF sample numbers have reported clear differences in IL-17A and in IL-17A/IL-17E ratios. 28 On the other hand, the IL-17A/IL-17E ratio correlated positively with CAL at implant sites in the present study.
The biofilm plays a significant role in initiation and progression of peri-implant and periodontal diseases. An animal study 46 and a human cross-sectional study 47 revealed that similar bacterial species are associated with periodontitis and peri-implantitis. Shibli et al. 48 evaluated supragingival and subgingival microflora and concluded that higher mean counts of Pg, Td, and Tf were observed in the peri-implantitis group. Canullo et al. 49 compared microbiologic composition at healthy implants and implants with peri-implantitis and, although orange complex species (Pi, Peptostreptococcus micros, Fn) were prevalent in both groups, their prevalence was higher in the peri-implantitis group. Implant sites were reported to be positive for Aa, Pg, Pi, Tf, and Td during the 10-day period after surgery. 50 Red complex microorganisms (Pg, Tf, and Td) were found to be more prevalent at peri-implantitis sites than at healthy implants. 39 Consistent with previous reports, 39, [48] [49] [50] significantly lower amounts of An, Pg, Fn, and Tf were detected in the healthy implant group than the mucositis group. Fn, Pg, Pi, and Tf levels were significantly higher in the peri-implantitis group than the healthy implant group.
CONCLUSIONS
Within the limitations of this cross-sectional study, some interesting data were obtained that may be relevant to differing levels of disease at implants and teeth. It might be concluded that peri-implant and periodontal sites in the same patients are similar in many aspects, but some differences in biomarker levels were seen, particularly in IL-1b, RANKL, and OPG. Furthermore, there were differences in the levels of a select number of bacterial species present at implants and teeth, and at both healthy and diseased sites around implants and the dentition.
